SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Development of the 2nd generation neurokinin-1 receptor antagonist LY686017 for social anxiety disorder
7 references·2 citing·30 second hop
Development of the 2nd generation neurokinin-1 receptor antagonist LY686017 for social anxiety disorder (2009)Development of the 2nd generation neuroki…Social Phobia (2015)Social PhobiaCerebral Blood Flow Changes After Treatment of Social Phobia with the Neurokinin-1 Antagonist GR205171, Citalopram, or Placebo (2005)Cerebral Blood Flow Changes A…Pharmacological treatment of social anxiety disorder: A meta-analysis (2003)Pharmacological treatment of …Handbook of Psychiatric Measures (2000)Handbook of Psychiatric Measu…The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10 (1998)The Mini-International Neurop…ECDEU Assessment Manual for Psychopharmacology (1976)ECDEU Assessment Manual for P…THE ASSESSMENT OF ANXIETY STATES BY RATING (1959)THE ASSESSMENT OF ANXIETY STA…A meta-analysis of pharmacotherapy for social anxiety disorder: an examination of efficacy, moderators, and mediators (2017)A meta-analysis of pharmacoth…Pharmacotherapy of social anxiety disorder (2011)Pharmacotherapy of social anx…Meta-analysis in clinical trials (1986)Anxiety disorders: a comprehensive review of pharmacotherapies (2008)Pharmacotherapy of anxiety disorders: a critical review (2011)Socially Anxious Primary Care Patients’ Attitudes Toward Cognitive Bias Modification (CBM): A Qualitative Study (2011)Diagnostic and Statistical Manual of Mental Disorders (2012)Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication (2005)Cognitive Behavioral Therapy, Sertraline, or a Combination in Childhood Anxiety (2008)Manual for the State-Trait Anxiety Inventory (1970)Recent advances in the neurobiology of anxiety disorders: Implications for novel therapeutics (2008)Diagnostic and Statistical Manual of Mental Disorders (2013)Relationships among cognition, emotion, and motivation: implications for intervention and neuroplasticity in psychopathology (2013)Biological markers for anxiety disorders, OCD and PTSD – a consensus statement. Part I: Neuroimaging and genetics (2016)Practical Meta-Analysis (2000)Trim and Fill: A Simple Funnel‐Plot–Based Method of Testing and Adjusting for Publication Bias in Meta‐Analysis (2000)A randomized clinical trial of group and individual Cognitive-Behavioral Therapy approaches for Social Anxiety Disorder (2019)Development of a new resilience scale: The Connor-Davidson Resilience Scale (CD-RISC) (2003)Psychometric properties of the PTSD checklist—civilian version (2003)Severity classification on the Hamilton depression rating scale (2013)Development and validation of the penn state worry questionnaire (1990)Psychometric properties of the 42-item and 21-item versions of the Depression Anxiety Stress Scales in clinical groups and a community sample. (1998)A Brief Measure for Assessing Generalized Anxiety Disorder (2006)The Yale-Brown Obsessive Compulsive Scale (1989)Children's Yale-Brown Obsessive Compulsive Scale: Reliability and Validity (1997)Cognitive-Behavioral Therapy for Adult Anxiety Disorders (2008)Short screening scales to monitor population prevalences and trends in non-specific psychological distress (2002)Epidemiology of anxiety disorders in the 21st century (2015)Gender differences in depression in representative national samples: Meta-analyses of diagnoses and symptoms. (2017)Cognitive Factors that Maintain Social Anxiety Disorder: a Comprehensive Model and its Treatment Implications (2007)World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders – First Revision (2008)Treatment of anxiety disorders (2017)
this work references cited by second hop

References

  • 1998The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-1019,139 cited
  • 1959THE ASSESSMENT OF ANXIETY STATES BY RATING11,442 cited
  • 1976ECDEU Assessment Manual for Psychopharmacology8,899 cited
  • 2015Social Phobia2,264 cited
  • 2000Handbook of Psychiatric Measures846 cited
  • 2005Cerebral Blood Flow Changes After Treatment of Social Phobia with the Neurokinin-1 Antagonist GR205171, Citalopram, or Placebo206 cited
  • 2003Pharmacological treatment of social anxiety disorder: A meta-analysis170 cited

Cited by

  • 2017A meta-analysis of pharmacotherapy for social anxiety disorder: an examination of efficacy, moderators, and mediators46 cited
  • 2011Pharmacotherapy of social anxiety disorder41 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work